A versatile 2A peptide-based bicistronic protein expressing platform for the industrial cellulase producing fungus, 
                   by unknown
Subramanian et al. Biotechnol Biofuels  (2017) 10:34 
DOI 10.1186/s13068-017-0710-7
RESEARCH
A versatile 2A peptide-based bicistronic 
protein expressing platform for the industrial 
cellulase producing fungus, Trichoderma reesei
Venkataramanan Subramanian1* , Logan A. Schuster1, Kyle T. Moore1, Larry E. Taylor II.1, John O. Baker1, 
Todd A. Vander Wall1, Jeffrey G. Linger2, Michael E. Himmel1 and Stephen R. Decker1
Abstract 
Background: The industrial workhorse fungus, Trichoderma reesei, is typically exploited for its ability to produce cellu-
lase enzymes, whereas use of this fungus for over-expression of other proteins (homologous and heterologous) is still 
very limited. Identifying transformants expressing target protein is a tedious task due to low transformation efficiency, 
combined with highly variable expression levels between transformants. Routine methods for identification include 
PCR-based analysis, western blotting, or crude activity screening, all of which are time-consuming techniques. To sim-
plify this screening, we have adapted the 2A peptide system from the foot-and-mouth disease virus (FMDV) to T. reesei 
to express a readily screenable marker protein that is co-translated with a target protein. The 2A peptide sequence 
allows multiple independent genes to be transcribed as a single mRNA. Upon translation, the 2A peptide sequence 
causes a “ribosomal skip” generating two (or more) independent gene products. When the 2A peptide is translated, 
the “skip” occurs between its two C-terminal amino acids (glycine and proline), resulting in the addition of extra amino 
acids on the C terminus of the upstream protein and a single proline addition to the N terminus of the downstream 
protein. To test this approach, we have cloned two heterologous proteins on either side of a modified 2A peptide, 
a secreted cellobiohydrolase enzyme (Cel7A from Penicillium funiculosum) as our target protein, and an intracellular 
enhanced green fluorescent protein (eGFP) as our marker protein. Using straightforward monitoring of eGFP expres-
sion, we have shown that we can efficiently monitor the expression of the target Cel7A protein.
Results: Co-expression of Cel7A and eGFP via the FMDV 2A peptide sequence resulted in successful expression of 
both test proteins in T. reesei. Separation of these two polypeptides via the modified 2A peptide was ~100% efficient. 
The Cel7A was efficiently secreted, whereas the eGFP remained intracellular. Both proteins were expressed when 
cloned in either order, i.e., Cel7A-2A-eGFP (C2G) or eGFP-2A-Cel7A (G2C); however, eGFP expression and/or function-
ality were dependent upon the order of transcription. Specifically, expression of Cel7A was linked to eGFP expression 
in the C2G orientation, whereas expression of Cel7A could not be reliably correlated to eGFP fluorescence in the G2C 
construct. Whereas eGFP stability and/or fluorescence were affected by gene order, Cel7A was expressed, secreted, 
and exhibited the expected functionality in both the G2C and C2G orientations.
Conclusions: We have successfully demonstrated that two structurally unrelated proteins can be expressed in T. ree-
sei using the FMDV 2A peptide approach; however, the order of the genes can be important. The addition of a single 
proline to the N terminus of eGFP in the C2G orientation did not appear to affect fluorescence, which correlated well 
with Cel7A expression. The addition of 21 amino acids to the C terminus of eGFP in the G2C orientation, however, 
appeared to severely reduce fluorescence and/or stability, which could not be linked with Cel7A expression. The 
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Background
Trichoderma reesei is well known for its ability to secrete 
cellulases at very high levels. Up to 100  g/L native cel-
lulases have been reported from mutated strains [1, 2]. 
There have been several advances made with respect to 
improving T. reesei strains for expression of native cellu-
lase enzymes [3–6]. These include the development of an 
efficient transformation system, varied selection mark-
ers, and strong promoters for expression of cellulases [7]. 
However, the use of T. reesei as a heterologous expres-
sion host has been limited to only a few select proteins 
(reviewed in [7]). Moreover, even successful protein-
expressing strains often have very low yields.
Several factors are considered important for expression 
of foreign genes in filamentous fungi, such as T. reesei, 
including transformation efficiency of the strain, codon 
bias, promoter strength, gene silencing effects, GC con-
tent of the gene, site of integration, copy number, and 
correct post-translational processing of heterologous 
proteins. Among these, the foremost consideration is the 
ability to transform the strain and identify positive trans-
formants from a pool of colonies. A transformant can be 
typically identified by growth on selective media; how-
ever, mere growth on selection media does not guaran-
tee the expression of the gene of interest (GOI) nor can 
it be used to predict the level of expression. For example, 
fragmentation or rearrangement of the plasmid construct 
prior to integration may lead to separation of the selecta-
ble marker from the GOI. As a consequence, additional 
techniques, such as PCR-based screening of individual 
transformants using gene-specific primers, western blot-
ting with specific antibodies to identify the protein of 
interest, or activity assays must be carried out in order to 
verify the presence of the GOI. Whereas these techniques 
are currently being used in T. reesei research, they are 
tedious when screening hundreds of colonies to find the 
best expressing transformant. Depending on copy num-
ber, its site(s) of integration, and the nature of the gene 
itself, the level of expression may be extremely low or 
essentially zero. The former two aspects can be addressed 
by targeted transformation into mutants lacking the 
non-homologous end-joining (NHEJ) pathway [8–11]. 
Using NHEJ mutant host strains, heterologous genes can 
be targeted into genomic locations where high express-
ing genes are typically present. Another commonly used 
strategy to track expressibility of a GOI is to fuse it to a 
trackable gene (such as a fluorescent, antibiotic, or aux-
otrophic marker) or a highly expressible native gene. 
However, such fusions may lead to alteration or even 
complete loss of function of the target or marker protein. 
Despite the availability of a few laborious (genomic DNA 
extraction, western blotting) and less reliable (colony 
PCR) techniques to identify the presence and expression 
of GOI, a simple, reliable, and robust way to ensure inde-
pendent GOI expression (i.e, without fusion) as well as 
identifying a positive GOI-expressing transformant from 
the pool of transformants is still lacking.
In theory, the use of viral 2A peptides ensures a 1:1 
expression ratio of the two linked genes. The 2A pep-
tides are found in many viruses, notably positive-strand 
RNA viruses, such as picornaviridae [12, 13]. The foot-
and-mouth disease virus (FMDV) genomes (prototypical 
Aphthovirus genus) contain a single, long, open reading 
frame that encodes a polyprotein of ~225 kDa. However, 
the full-length translation product is seldom found due 
to rapid “primary” discontinuous polyprotein transla-
tion occurring at the C-terminal end of the 2A peptide 
sequence found within this ORF [13]. The FMDV 2A 
peptide contains a specific 19 amino acid sequence that 
“auto-separates” the viral polyproteins during transla-
tion [14–16]. The mechanism of separation of the poly-
proteins involves hydrolysis of the nascent polypeptide 
from the tRNA during ribosomal translation of the 2A 
peptide sequence, wherein the peptidyl (2A)-tRNAGly 
ester linkage to the glycyl-tRNA in the ribosomal P-site 
is hydrolyzed, thereby releasing the nascent polypeptide 
from the ribosomal translational complex. Continued 
synthesis of the downstream protein sequence start-
ing with the sequential proline on the C terminus of the 
2A peptide sequence still occurs [15]. It appears that the 
downstream polypeptide is never directly bound to the 
upstream protein through a peptide bond. Instead, the 
2A sequence induces hydrolysis of the upstream protein 
2A glycine (position 18 in native FMDV 2A) from its 
molecular biology tool that we have implemented in this study will provide an efficient strategy to test the expression 
of heterologous proteins in T. reesei, while also providing a novel platform for developing this fungus as an efficient 
multi-protein-expressing host using a single polycistronic gene expression cassette. An additional advantage of this 
system is that the co-expressed proteins can be theoretically produced at equimolar ratios, as (A) they all originate 
from a single transcript and (B) unlike internal ribosome entry site (IRES)-mediated polycistronic expression, each 
cistron should be translated equimolarly as there is no ribosomal dissociation or reloading between cistrons.
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tRNA. The position 19 proline tRNA still complexes with 
the ribosome but instead of being linked to the 18-gly-
cine, it is used as the N terminus of a new polypeptide. 
Two independent proteins are thus produced due to the 
lack of formation of a peptide bond during the transla-
tion process, also referred to as “ribosomal-skip” mecha-
nism [15]. Referencing the 2A peptide as “self-cleaving” is 
somewhat of a mischaracterization, as the two translated 
sequences are never covalently linked. This mechanism 
of discontinuous protein translation has been shown 
to be specific to eukaryotic 80S ribosomes only (not to 
70S prokaryotic ribosomes). Donnelly et  al. [12] also 
observed ~90% cleavage activity with a 19 amino acid 2A 
peptide sequence, which was further enhanced to ~96% 
by the addition of as few as five amino acids to the N-ter-
minal end of the 2A peptide [14]. Further addition of 
amino acids (up to 39 amino acids) to the N-terminal end 
resulted in increasing cleavage efficiency to ~100% [14].
The advantage of the 2A peptide system is that two 
or more independent proteins can be produced at near-
stoichiometric levels unlike internal ribosome entry site 
(IRES)-mediated polycistronic expression where ribo-
somes are independently recruited at distinct regions 
with the mRNA [14, 15, 17, 18]. Up to nine proteins have 
been linked and successfully co-translated and separated 
with 2A sequences in a methylotrophic yeast, Pichia 
pastoris [19]. With respect to T. reesei, the 2A peptide 
approach could drastically reduce the time for screen-
ing of high GOI-expressing transformants if a simple 
marker protein was included. Here, we report successful 
co-expression of two independent heterologous proteins 
in T. reesei; cellobiohydrolase Cel7A from Penicillium 
funiculosum and a fluorescent marker protein eGFP, 
separated by a 22 amino acid modified FMDV 2A pep-
tide sequence. Both proteins are produced as separate 
polypeptides from a single transcript with an observed 
2A separation efficiency of ~100% based on western blot 
analysis. Availability of this molecular tool will dramati-
cally improve the transformation screening efficiency and 
further develop T. reesei as a robust protein expression 
host, where multiple proteins can be expressed simulta-
neously for both academic and industrial pursuits. Aside 
from co-expression of various industrial enzymes, this 
tool could be exploited for expression of complete meta-
bolic pathways to generate similar stoichiometric levels 
of proteins for bioproducts synthesis from T. reesei.
Results and discussion
An efficient way to identify and track transformants 
expressing heterologous and homologous genes has 
been lacking in eukaryotic organisms, such as T. ree-
sei. Although expressing colonies can be identified by 
intensively screening the transformants by western blot 
analysis or protein activity assays, this is extremely dif-
ficult for proteins lacking specific antibodies or with no 
functional activity assays. Here we have presented a sim-
ple and efficient way of detecting successful expression 
of genes (foreign or native) using a 2A peptide-driven 
approach.
Transformation of FMDV 2A peptide in T. reesei
We generated two different plasmids using pTrEno 
(hygromycin resistance marker and strong constitutive 
strong eno promoter) as the starting vector such that the 
eGFP and Cel7A genes were on either sides of the modi-
fied 2A peptide sequence [14–16]. The two vectors con-
tained the same genes in inverse order; Cel7A-2A-eGFP 
(C2G) or eGFP-2A-Cel7A (G2C). The constructs, when 
successfully expressed, should result in two proteins 
separated between the glycine 21 and proline 22 within 
the 2A peptide sequence, with the protein downstream 
of the 2A peptide containing an extra proline at the N 
terminus and the upstream protein containing an addi-
tional 21 amino acids at its C-terminal end. The expres-
sion cassette is as shown in Fig.  1. Transformation of 
both these constructs resulted in hygromycin-resistant 
colonies. As a first step toward predicting Cel7A protein 
expression via co-expression of eGFP, we tested 22 hygr 
colonies for eGFP expression based on fluorescence using 
a Safe Imager 2.0 blue light transilluminator (470  nm, 
ThermoFisher Scientific Inc., Grand Island, NY, USA). 
Although, there was noticeable visual difference between 
the fluorescence levels in these micro-cultures (data not 
shown), it was difficult to identify actual eGFP-express-
ing colonies from the pool of transformants using this 
instrument due to low-level background fluorescence of 
T. reesei.
Confirmation of efficient cleavage of 2A peptide in T. reesei
Since it was difficult to positively identify eGFP-express-
ing clones under blue light (background fluorescence), 
we identified positive Cel7A-expressing clones by west-
ern blotting. Our analysis revealed that Cel7A-expressing 
clones were detected with a very low frequency. Only two 
of 12 transformants screened showed detectable Cel7A 
expression, to varying degrees, among each of the C2G 
and G2C transformants (Fig. 2). Among the C2G trans-
formants, colonies A4 and A5 showed Cel7A expres-
sion, with A5 being the best expressing clone (Fig. 2, left 
panel). Expression of Cel7A in colony A4 was extremely 
low. Among the G2C transformants, colonies C2 and 
D2 showed Cel7A expression with C2 expressing bet-
ter than the D2 clone. This observation highlighted the 
low efficiency and high variability of protein expression 
in this eukaryotic system, even in hygromycin-resistant 
transformants. The estimated molecular weight of Cel7A, 
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as detected in the western blot, was  ~53  kDa, which is 
the expected size of intact Cel7A (Fig. 2). If the 2A pep-
tide had not efficiently separated, the apparent molecu-
lar weight would have been  ~82  kDa (52.5  kDa for 
Cel7A + 2.3 kDa for 2A + 26.9 kDa for eGFP). This dem-
onstrated that the 2A peptide was effective in both gene 
arrangements.
In order to determine the consistency of fluorescence 
to Cel7A expression, we generated five clonal isolates for 
two transformants that showed varying degrees of Cel7A 
expression; as well as visual eGFP fluorescence from 
each of the 2A orientation cassettes. The selected C2G 
transformants were A4 (very low fluorescence) and A5 
(very high fluorescence) and C2 (high fluorescence) and 
Fig. 1 Constructs used in this study. a Modified FMDV 2A peptide sequence used in this study. Red arrow represents the site of ribosomal skipping. 
The long blue arrow represents the peptide that gets added to the C-terminal end of the upstream protein. The short blue arrow represents the 
amino acid (proline) that gets added to the N-terminal end of the downstream protein. b Bicistronic gene constructs for testing expression of Cel7A 
and eGFP protein in T. reesei. Cel7A and eGFP are separated by FMDV 2A peptide sequence in either orientation (left panel and right panel). Upon 
transcription of the bicistronic gene construct, a single mRNA transcript containing eGFP and Cel7A are produced, which upon translation gets 
cleaved after the glycine residue within the 2A peptide to yield two independent proteins. 21 amino acids of the 2A peptide get added to the pro-
tein upstream of the peptide and one amino acid (proline) gets added to the downstream protein. Horizontal arrows and the numbers 1, 2, and 3, 
below the gene cassettes, represent PCR products that were used to confirm the presence of individual genes in the transformants. c Plasmid maps 
of the two constructs used in this study. The restriction site, SbfI, represents the site of linearization of the plasmid. Eno enolase, PGK1 phosphoglyc-
erate kinase, HPT hygromycin phosphotransferase, term terminator
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D2 (medium fluorescence) for the G2C transformants 
(Fig.  2). Clonal isolates were obtained by restreaking a 
spore suspension obtained from each of the four positive 
Cel7A transformants onto hygromycin selection plates. 
Five individual colonies arising from this restreak were 
inoculated into MAG medium containing hygromycin. 
We observed that these clonal isolates clearly displayed 
consistent degrees of fluorescence based on blue light 
visualization (Fig. 3a) that represented the varied expres-
sion levels in the parental strains. Whereas A4 and A5 
clones displayed better fluorescence, C2 and D2 clones 
showed poor fluorescence (Fig. 3a). Western blotting was 
performed on cell-free media, which showed that in the 
C2G orientation, A4 and A5 clones showed relatively 
high levels of Cel7A protein (Fig. 3b, right panel). On the 
other hand, in the G2C orientation, C2 clones showed 
higher Cel7A protein expression than D2 (Fig.  3b, left 
panel). In order to confirm if this result correlated with 
eGFP protein expression, we performed western blotting 
of intracellular protein extract using anti-eGFP antibody. 
It should be noted that no detectable eGFP expression 
was detected extracellularly in any of these clonal isolates 
via visual fluorescence observation or western blot analy-
sis (data not shown). We observed that eGFP protein was 
expressed at relatively similar levels in the C2G strains 
A4 and A5—that is low levels in A4 and high levels in 
A5 (Fig.  3c, right panel). In contrast, eGFP was barely 
detectable in the G2C strains. Specifically, C2 showed 
very low eGFP levels and D2 did not show eGFP bands 
at the expected molecular weight (Fig.  3b, left panel). 
These observations highlight that the arrangement of the 
two genes can be critical in using 2A systems, wherein 
the 2A remnants can have potential deleterious effects 
on the target proteins. A promising observation is that 
both Cel7A and the eGFP proteins were expressed at 
the expected molecular weight (i.e.,  ~53  kDa for Cel7A 
and ~27 kDa for eGFP). No detectable expression of an 
uncleaved protein product at  ~82  kDa was observed in 
the western blots. This suggested that the 2A peptide was 
being cleaved at  ~100% efficiency and was resulting in 
the generation of the two complete gene products, Cel7A 
and eGFP in T. reesei.
Cel7A is functional in either sequence
Once we observed that eGFP stability/fluorescence was 
affected by its position within the 2A cassette, we ques-
tioned whether or not the activity of Cel7A was also 
affected in a similar manner. To answer this question, 
we purified Cel7A proteins to homogeneity from either 
sequence using extensive Fast Protein Liquid Chroma-
tography (FPLC). The specific clones used for purification 
were SV001 (eGFP-2A-Cel7A #C2-1, Fig. 3a) and SV004 
(Cel7A-2A-eGFP #A5-4, Fig.  3a). The purified proteins 
were observed as single bands of ~53 kDa on SDS-PAGE 
(Fig.  4a, b). We performed in  vitro biomass hydrolysis 
assays of dilute acid-pretreated corn stover using these 
purified Cel7A proteins plus standard endocellulase and 
β-d-glucosidase to quantify the cellulose conversion effi-
ciency of Cel7A obtained from these two gene orienta-
tions. Our analysis showed that Cel7A obtained from 
both orientations displayed similar conversion profiles 
(Fig. 4c). The rate of cellulose conversion activity of these 
two Cel7A variants was comparable to the rate of con-
version of native P. funiculosum Cel7A (Fig.  4c). As the 
Cel7A contains a secretion signal peptide sequence that 
gets cleaved during secretion of the processed protein, 
the resultant final protein from the G2C is the same as 
the native sequence. The addition of a single proline to 
Fig. 2 Screening of transformants for identification of Cel7A-expressing colonies. Individual transformant colonies arising from the two differ-
ent plasmid constructs (cel7A-2A-eGFP and eGFP-2A-Cel7A) were transferred to liquid medium containing hygromycin and grown for 3 days at 
30 °C. Western blotting of secretome was performed for a few of the selected colonies from the 24-well plates using anti-Cel7A antibody. Lanes. M 
molecular weight marker, A, B, C, and D followed by numbers represent well coordinates, C Cel7A control
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the N terminus of the Cel7A signal sequence does not 
appear to negatively affect secretion. In the C2G, Cel7A 
activity also remained unaffected, suggesting that the 
expressed protein was able to undergo proper folding and 
retained a conformation very close to that of the native 
protein. It is especially telling that activity was measured 
Fig. 3 Demonstration of efficient cleavage of the FMDV 2A peptide in T. reesei. Clonal isolates of the two FMDV 2A-based constructs were com-
pared for their eGFP fluorescence and for their efficiency in expressing Cel7A protein. a Individual clonal isolates were transferred to liquid media 
and incubated for 3 days at 30 °C in 24-well culture plates. eGFP fluorescence was visualized under blue light. Each of the rows represents five 
independent clones from a single Cel7A-expressing transformant. +ve and –ve indicate wells containing Cel7A-expressing and Cel7A-deleted 
transformants, respectively. b Western blotting of secretome from individual wells using anti-Cel7A antibody. c Western blotting of intracellular 
protein extract from individual clonal isolates using anti-eGFP antibody. Lanes M marker, 1, 2, 3, 4, 5, correspond to individual well coordinates, C2, 
D2, A4, and A5, represent original Cel7A-expressing transformants from which clonal isolates were generated, JLT102A (AST1116 expressing native 
Cel7A under the eno promoter), AST1116 (Cel7A-deleted T. reesei QM6a strain)
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on an insoluble lignocellulosic substrate, indicating that 
the C-terminal cellulose-binding domain of Cel7A is 
fully functional, despite the extra 21 amino acids added 
C-terminally. This retained functionality is indicative that 
other C-terminal tags may be used to monitor Cel7A.
Expression of Cel7A can be correlated to eGFP fluorescence 
when expressed in the C2G orientation
The purpose of this approach was to use eGFP as a 
marker for monitoring expression of proteins, such as 
Cel7A (in this study); as well as other difficult to moni-
tor heterologous proteins in future T. reesei studies. 
Initially, it proved to be difficult to monitor eGFP expres-
sion with simple blue light fluorescence measurement. 
Therefore, we decided to quantify the eGFP fluorescence 
using a FLUOstar Omega plate reader (BMG Labtech 
GmbH, Ortenburg, Germany) and compare fluorescence 
units (FLU) to the level of Cel7A expression by western 
blotting. This was carried out by transferring 63 indi-
vidual colonies of each gene orientation from transfor-
mation plates into liquid medium containing hygromycin 
(100  µg/mL) in 24-well plates. After allowing growth of 
the mycelial mat, fluorescence measurement was per-
formed using the plate reader (Figs.  5, 6, 7). Simultane-
ously, we also used a FluorChem Q imaging system (Cell 
Biosciences, Santa Clara, CA, USA) to visually differenti-
ate fluorescent colonies from the low or non-fluorescent 
colonies (Figs. 5b, 6b). We observed that the fluorescent 
signal measurements ranged from  ~3000 to  ~15000 
FLUs in the different wells (Fig. 7), with relatively few at 
the upper end (>9000) and the majority at ~4000 or less. 
We did not observe any “medium” fluorescence colonies. 
This may be due to the “enhanced” nature of the eGFP 
providing high fluorescence even at lower levels or, more 
simply, that the three days growth provided enough time 
for positive expressing colonies to saturate themselves 
with eGFP regardless of expression levels. We picked all 
the high fluorescence wells (four for C2G, one for G2C) 
and numerous random representatives of low-fluores-
cence colonies for each group to confirm the expression 
of Cel7A by western blotting (Figs. 5c, 6c). We observed 
that the low fluorescent colonies did not show expression 
of Cel7A in the C2G orientation (Figs.  5, 7a). However 
those colonies showing fluorescence of over 9000 FLUs 
showed high levels of Cel7A expression in this orienta-
tion (Figs. 5, 7a).
We further observed that in the C2G orientation, 
expression of eGFP was directly related to the expres-
sion of Cel7A (Fig. 5). All the colonies that showed fluo-
rescence on the plate (Fig. 5a, b) also showed expression 
of Cel7A in the western blot analysis (Fig.  5c). In con-
trast, this was not the case with the G2C orientation. In 
the G2C population, the low fluorescent colonies varied 
in Cel7A expression (Figs. 6, 7b). A few of them, such as 
DB6, DC1, DD5, EA2, and EC4, showed positive Cel7A 
expression (Figs.  6, 7b). As could be expected from the 
fluorometer results, these colonies did not show sig-
nificant fluorescence under the FluorChem Q imaging 
Fig. 4 Cel7A protein purification and enzyme activity of the purified protein on pretreated corn stover (PCS) as a substrate. a Coomassie-stained 
SDS-PAGE gel showing a single band of ~53 kDa purified Cel7A protein. b A parallel SDS-PAGE gel was used to identify the purified proteins by 
western blotting using anti-Cel7A antibody. c Cellulase enzyme activity of Cel7A proteins obtained from expression of the two different versions of 
the 2A cassette (i.e., G2C and C2G), compared to purified P. funiculosum Cel7A, shows similar conversion pattern. M molecular weight marker, Lanes 
1 and 2 represent purified Cel7A proteins from G2C and C2G cassettes, respectively. Lane C represents purified P. funiculosum Cel7A
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system, indicating that even though they were express-
ing Cel7A, eGFP was not a reliable indication of Cel7A 
expression. The sole high fluorescent colony (EA1) 
showed Cel7A expression similar to the C2G orientation 
(Figs. 6c, 7b). These results clearly suggest that in the G2C 
orientation, the fluorescence measurement cannot neces-
sarily be correlated to the expression of Cel7A protein, 
especially in the low fluorescent clones. While we can-
not explain the single high eGFP/high Cel7A clone, the 
overall low fluorescence, even among the Cel7A positive 
clones, could be explained by the fact that in the G2C ori-
entation, a 21 amino acid remnant of the FMDV 2A pep-
tide gets added to the C-terminal end of the processed 
eGFP protein (after cleavage of the 2A peptide), which is 
not the case with the C2G orientation. We speculate that 
addition of 21 amino acids to the eGFP C terminus affects 
the overall stability of the protein, causes mis-folding, or 
interference with the fluorescence through quenching or 
electron transfer interference, resulting in lower levels of 
eGFP and/or lower fluorescence. Low anti-eGFP western 
blot detection suggests that degradation of eGFP from 
the G2C constructs is causing the discontinuity between 
Cel7A and eGFP protein levels in the G2C order. We can-
not, however, rule out that the extra 21 amino acids on 
the G2C are interfering with anti-GFP antibody binding 
and detection. The single proline added to the N termi-
nus of eGFP in the C2G orientation is much less likely to 
interfere with protein stability or function.
In order to determine if the lack of Cel7A or eGFP 
expression was due to non-insertion of gene(s) into the 
genome or due to fragmentation of the expression cas-
sette, we performed genomic PCR analysis on colonies 
Fig. 5 Correlation between fluorescence intensity and Cel7A expression in the C2G orientation. Individual transformants were transferred to three 
24-well plates containing MAG medium supplemented with hygromycin and allowed to grow for 3 days at 30 °C. Rows are labeled as A–D. Columns 
are labeled as 1–6. Plates are labeled as plate A, plate B, and plate C. a Mycelia-containing plates visualized under blue light. b The same plates were 
also visualized using FluorChem Q imaging system (Cell Biosciences, Santa Clara, CA, USA). c Western blotting on selected colonies using anti-Cel7A 
antibody. Each lane represents secretome obtained from one well of the 24-well plate. M marker, letters followed by numbers represent coordinates 
on the 24-well plates. The first letter represents the plate ID, the second letter represents the row, and numbers following the two letters represent 
the column number. Coordinates D4, D5, and D6 in each plate represent the control strains, AST1116 (Cel7A-deleted T. reesei QM6a strain), JLT102A 
(AST1116 expressing native Cel7A under the eno promoter), and SV004 (Cel7A-2A-eGFP cassette containing very high eGFP fluorescence strain; 
colony A5-4 in Fig. 3a)
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generated from an independent transformation experi-
ment from both the gene cassettes (Tables  1, 2). The 
specific gene products used to confirm the presence 
of cel7A, eGFP, or both within the cassette are shown 
in Fig.  1b. The primers used in this analysis are shown 
in Additional file  1. We observed that all colonies that 
showed Cel7A expression to detectable levels (Tables  1, 
2; Additional files 2 and 3), irrespective of their fluores-
cent intensities, show the presence of both cel7a and 
eGFP genes (Tables 1, 2; Additional files 3 and 4). Colony 
A2 in the C2G orientation, which did not show detect-
able levels of either Cel7A or eGFP, showed the presence 
of only eGFP by PCR analysis (Table 1; Additional files 2 
and 4). This demonstrated an instance where insertion 
of eGFP and hygromycin into the genome, albeit with-
out eGFP expression. On the other hand, colony A4 in 
the C2G orientation showed no Cel7A or eGFP expres-
sion although the presence of the entire gene cassette 
was confirmed by PCR analysis (Table 1; Additional files 
2 and 4), suggesting that the location of insertion most 
likely resulted in lack of expression of the gene cassette. 
Colony B1 in the G2C orientation showed weakly posi-
tive PCR signals for both cel7A and eGFP and absolutely 
no expression of either gene products (Table  2; Addi-
tional files 3 and 5), suggesting a possible copy number 
effect. A more striking observation was that despite hav-
ing high levels of Cel7A in six of the eight G2C transfor-
mants (Table  2; Additional file  3), eGFP expression was 
extremely low in these transformants suggesting that the 
stability or fluorescence of eGFP protein was particu-
larly affected in this orientation, likely due to the addi-
tion of the C-terminal 21 aa tag. Moreover, even the best 
Fig. 6 Correlation between fluorescence intensity and Cel7A expression in the G2C orientation. Individual transformants were transferred to three 
24-well plates containing MAG medium supplemented with hygromycin and allowed to grow for 3 days at 30 °C. Rows are labeled as A–D. Columns 
are labeled as 1–6. Plates are labeled as plate A, plate B, and plate C. a Mycelia-containing plates visualized under blue light. b The same plates were 
also visualized using FluorChem Q imaging system (Cell Biosciences, Santa Clara, CA, USA). c Western blotting on selected colonies using anti-
Cel7A antibody. Each lane represents secretome obtained from one well of the 24-well plate. M marker, Alphabets followed by numbers represent 
coordinates on the 24-well plates. The first alphabet represents the plate ID, the second alphabet represents the row, and numbers following the two 
alphabets represent the column number. Coordinates D4, D5, and D6 in each plate represent the control strains, AST1116 (Cel7A-deleted strain), 
JLT102A (Cel7A-expressing strain in a Cel7A null background), and SV004 (Cel7A-2A-eGFP cassette containing very high eGFP fluorescence strain; 
colony A5-4 in Fig. 3a)
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Fig. 7 Fluorescence signal intensity of individual transformants and correlation with expression of Cel7A by western blotting. a Transformants for 
Cel7A-2A-eGFP were analyzed for fluorescence intensity and Cel7A expression. b Transformants for eGFP-2A-Cel7A were analyzed for fluorescence 
intensity and Cel7A expression. Fluorescence intensity was measured using FLUOstar Omega plate reader (BMG Labtech GmbH) and is represented 
using arbitrary fluorescence units. Western blotting was performed on cell-free media as shown in Figs. 4 and 5. Each bar represents data obtained 
for a single transformant colony. Blue bars indicate transformants showing no Cel7A expression. Yellow bars indicate transformants showing Cel7a 
expression. Red bars represent control strains. Controls: JLT102A (AST1116 expressing native Cel7A under the eno promoter), AST1116 (Cel7A-
deleted T. reesei QM6a strain), and SV004 (AST1116 expressing Cel7A-2A-eGFP; colony A5-4 in Fig. 3a)
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Cel7A-expressing transformant in this orientation (C6 
and D1, Table 2; Additional file 3) showed lower fluores-
cence and lower eGFP, in comparison to the best Cel7A-
expressing transformants C2 and C5 from the C2G 
orientation (Table 1; Additional file 2).
It is known that some heterologous proteins do not 
express well in T. reesei unless fused to a native “leader” 
protein domain. We did not express eGFP as a single 
gene construct in order to confirm that it is expressible 
in T. reesei, and the fluorescence measured in the C2G 
Table 1 PCR analysis of selected C2G transformants along with their protein expression and fluorescence intensity meas-
urements
Fluorescent intensities are shown in arbitrary fluorescence units (FLU)
+ and − under western blot and PCR analysis columns represent presence or absence of the protein and gene, respectively, Faint represents very low, but detectable 
levels of the respective protein, ND denotes no data available, Controls JLT102A (AST1116 expressing native Cel7A under the eno promoter), AST1116 (Cel7A-deleted T. 
reesei QM6a strain), SV001 and SV002 (AST1116 expressing eGFP-2A-Cel7A; colonies C2-1 and D2-1 in Fig. 3a), and SV004 (AST1116 expressing Cel7A-2A-eGFP; colony 
A5-4 in Fig. 3a)
Transformants Fluorescence  
intensity
Western blot analysis PCR analysis
Cel7A eGFP PCR-1 PCR-2 PCR-3
A1 8393 + + + + +
C2 16,062 + + + + +
C4 2462 + + + + +
C5 17,975 + + + + +
D1 4358 + + + + +
D3 7360 + + + + +
A2 1976 − − − + −
A4 2736 − − + + +
AST1116 2130 − − − – −
JLT102 2088 + − − – −
SV001 ND + + − + +
SV002 ND + + − + +
SV004 10,539 + + + + +
Table 2 PCR analysis of selected G2C transformants along with their protein expression and fluorescence intensity meas-
urements
Fluorescent intensities are shown in arbitrary fluorescence units (FLU)
Controls: JLT102A (AST1116 expressing native Cel7A under the eno promoter), AST1116 (Cel7A-deleted T. reesei QM6a strain), SV001 and SV002 (AST1116 expressing 
eGFP-2A-Cel7A; colonies C2-1 and D2-1 in Fig. 3a), SV004 (AST1116 expressing Cel7A-2A-eGFP; colony A5-4 in Fig. 3a)
+ and − under western blot and PCR analysis columns represent presence or absence of the protein and gene, respectively, Faint represents very low, but detectable 
levels of the respective protein, ND denotes no data available
Transformants Fluorescence  
Intensity
Western blot analysis results PCR analysis results
Cel7A eGFP PCR-1 PCR-2 PCR-3
C6 6193 + + + + +
D1 6837 + + + + +
C2 4194 + Faint + + +
A1 4444 + Faint + + +
A2 3684 + + + + +
C3 3822 + + + + +
C4 2099 Faint − + + +
B1 2352 − − + + −
AST1116 2032 − − − − −
JLT102 2204 + − + − −
SV001 ND + + + + +
SV002 ND + + + + +
SV004 13892 + + + + +
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orientation could be interpreted as evidence that eGFP 
requires a leading peptide sequence for expression in T. 
reesei; however, the high level of Cel7A present in multi-
ple G2C constructs negates this conclusion. In order for 
Cel7A to be expressed in the G2C construct, the eGFP 
must be translated first.
Given the theoretical equimolar expression levels of 2A 
peptide-linked proteins, we expected to be able to corre-
late eGFP expression level measured by fluorescence to 
Cel7A expression level measured by western blot. Our 
intention was to identify colonies with varying levels of 
eGFP fluorescence and measure similarly varying levels of 
Cel7A. In all cases of high eGFP expression, we observed 
high Cel7A expression; however, the inverse, low/no 
eGFP and accompanying low/no Cel7A, was only consist-
ent in the C2G case. In the other orientation (i.e., G2C), it 
is more stochastic, where even though eGFP fluorescence 
was low, Cel7a expression was still observed in some 
clones. This result indicates that decreased expression 
and/or functionality of eGFP due to added C-terminal 
amino acids to the final protein make the G2C orientation 
less reliable for transformant screening purposes. How-
ever, based on Cel7A activity experiments, it is clear that 
Cel7A activities, in both the orientations, are the same.
Conclusions
Although T. reesei is known as a versatile cellulase-pro-
ducing fungus and has been exploited intensively for this 
purpose, expressing heterologous proteins still remains 
a challenge in this organism. Here, we have demon-
strated the use of a novel bicistronic expression platform 
to monitor co-expression of heterologous genes using 
eGFP as a marker. Our results have unequivocally dem-
onstrated that two genes can be expressed successfully in 
T. reesei in a bicistronic manner from a single transcript 
using the 2A peptide approach. We have also shown that 
eGFP can be used as a fluorescent marker in T. reesei and 
that the levels of the transgene expression (in this case, 
cbh1) can be directly correlated to that of eGFP. We have 
also verified that the Cel7A activity toward pretreated 
corn stover is not affected by its orientation within the 
2A cassette, although eGFP expression and/or stability 
are affected when specifically placed in the orientation 
that adds 21 amino acids to its C-terminal end (i.e., G2C 
orientation). We propose that this approach can be fur-
ther extended to other cellulases in T. reesei and possibly 
to other transgenes, as long as addition of amino acids 
to the gene products’ C terminus does not affect their 
function. Furthermore, the 2A peptide approach can be 
expanded for expression of multiple proteins simultane-
ously by introducing additional 2A peptide sequences 
between genes. Future work in our lab will involve 
developing this approach toward expressing complete 
metabolic pathways, as well as multiple biomass conver-
sion enzymes from a single transcript.
Methods
Strains and growth conditions
The T. reesei strains AST1116 and JLT102A used in this 
study were routinely maintained on Mandels Andreotti 
minimal medium containing 5% glucose (MAG) as 
described in Linger et  al. [5]. For strains resistant to 
hygromycin, MAG medium was supplemented with 
100  µg/mL of this antibiotic. AST1116 was derived 
from T. reesei (Trichoderma reesei) QM6a by deletion 
of the native cbh1 gene [6]. JLT102A was derived from 
AST1116 by insertion of the native T. reesei cbh1 gene 
under the control of a constitutive eno promoter [5].
Plasmid construction
The vector pTrEno-PF was used as a parent vector [5]. 
Two different FMDV 2A peptide-based constructs were 
designed by Genscript (Piscataway, NJ, USA). The first 
one, pTrEno-Cel7A-2A-eGFP (C2G) was constructed 
as follows. The FMDV 2A peptide sequence and an 
enhanced Green Fluorescent Protein (eGFP) sequence 
were codon optimized and synthesized by Genscript such 
that the 2A and the eGFP sequences were in-frame with 
each other. Furthermore, an XbaI site was introduced at 
either ends of this 2A-eGFP cassette so as to introduce 
this cassette into the pTrEno-PF vector into the XbaI 
site. Note that neither the 2A nor the eGFP sequences 
included a start codon. Additionally, the stop codon was 
also eliminated from the Cel7A gene so as to have a con-
tiguous Cel7A-2A-eGFP gene sequence with one start 
codon at the 5′ end of Cel7A gene and a stop codon at the 
3′ end of eGFP coding sequence.
The second vector, pTrEno-eGFP-2A-Cel7A (G2C), 
was constructed as follows by Genscript. Briefly, a 
codon-optimized eGFP sequence along with a 2A pep-
tide sequence was synthesized with a PacI and a BamHI 
restriction sites flanking its 5′ and 3′ ends. This eGFP-
2A cassette was introduced into the pTrEno-PF vec-
tor using PacI and BamHI restriction sites. Note that 
BamHI restriction site was built into the parent vector 
by PCR. The resulting vector now had the following gene 
sequence eGFP-2A-Cel7A. This contiguous gene cassette 
had only one start codon at the 5′ end of the eGFP gene 
and a stop codon at the 3′ end of the Cel7A gene.
Transformation of plasmids into T. reesei
Competent spores were prepared as described in Lin-
ger et  al. [5], which involved time-specific sporulation 
on potato dextrose agar (PDA), followed by re-sporu-
lation, collection, and washing of spores before freez-
ing at −80  °C as electro-competent spore stocks. 5 µg 
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of plasmid was linearized with SbfI and further purified 
using DNA clean and concentrator-5 kit (Zymo Research 
Corp, Irvine, CA). Frozen competent spores were thawed 
on ice and mixed with ~1.0 µg of the linearized plasmid. 
Electroporation was carried out using a Bio-Rad Gene 
Pulser (Bio-Rad Laboratories, Inc., Hercules, CA, USA) 
using the following conditions: 1.8 kV, 25 µF, 800 Ω, and 
incubated for few min on ice. 1 mL of ‘complete medium 
lactose’ medium was then added to the transformation 
mixture and transferred to six-well tissue culture plates 
and incubated at RT for 18 h to allow recovery and ger-
mination of spores. 200 µL of this cell suspension was 
then plated on PDA containing 100  µg/mL hygromycin 
and 0.1% (v/v) Triton X-100 for colony size restriction 
(PDHX) and incubated at 30  °C in lighted incubator for 
2–3 days to allow colony development.
Screening of transformants by western blotting
A small piece of mycelial fragment from transformant col-
onies grown on PDHX plates was transferred to 2  mL of 
MAG medium containing hygromycin (100  µg/mL) in a 
24-well microtiter plate and incubated statically in a lighted 
30 °C incubator for 3 days till a mycelial mat was observed 
on the liquid medium. 15 µL of cell-free culture broth (con-
taining secreted proteins) was transferred to microcentri-
fuge tubes containing 5 µL SDS-PAGE loading buffer and 
subjected to boiling at 95 °C for 10 min. This protein extract 
was separated on 4–12% NuPAGE gel in MOPS buffer 
(200 V for 50 min). Post-separation, proteins were electro-
transferred onto PVDF membrane for western blot analy-
sis using an iBlot2 (Thermo Fisher Scientific, Inc. Grand 
Island, NY, USA). For hybridization of Cel7A protein, a 
custom generated P. funiculosum anti-Cel7A polyclonal 
antibody raised in rabbit was used as primary antibody at a 
dilution of 1:20,000. For detection of eGFP, anti-GFP anti-
body raised in mouse (Thermo Fisher Scientific Inc., Grand 
Island, NY, USA) was used as the primary antibody. Detec-
tion of cel7A and eGFP proteins was carried out using alka-
line phosphatase-conjugated anti-rabbit secondary antibody 
(Thermo Fisher Scientific, Inc. Grand Island, NY, USA), and 
HRP-conjugated anti-mouse secondary antibody (Thermo 
Fisher Scientific, Inc., Grand Island, NY, USA), respectively.
Cel7A purification
The Cel7A was purified as described earlier [5]. Briefly, 
fermentation broths (~8–10  L) were harvested, vacuum 
filtered, concentrated, and then loaded onto a 26/10 Phe-
nyl Sepharose Fast Flow column. Buffer A was 20  mM 
Bis–Tris pH 6.5 and buffer B was 20 mM Bis–Tris pH 6.5, 
2.0 M (NH4)2SO4. After binding and washing, a descend-
ing gradient of 80% B (1.6  M (NH4)2SO4) to 0% B over 
eight column volumes was used to elute the bound pro-
teins from the column. Active fractions were identified 
by a p-nitrophenyl-β-(1→4)-d-lactopyranoside (pNP-L) 
activity assay. The pNP-L-active fractions were pooled 
and concentrated as needed. Protein was desalted and 
exchanged into 20 mM Bis–Tris buffer pH 6.5. This sam-
ple was then loaded onto a Tricorn 10/100 anion exchange 
column packed with Source 15Q and eluted with a 0–50% 
salt gradient over 30 column volumes. Buffers were 
20 mM Bis–Tris pH 6.5 (A) and the same supplemented 
with 1.0 M NaCl (B). pNP-L activity was followed again to 
identify the active fractions. Active fractions were pooled, 
brought to 1.5 M (NH4)2SO4 in 20 mM Bis–Tris pH 6.5, 
loaded onto a Tricorn 10/100 Source-Iso column, washed, 
and eluted with a descending gradient from 1.6 to 0.4 M 
(NH4)2SO4. Active fractions were concentrated to <10 mL 
and subjected to size exclusion chromatography using a 
26/60 Superdex 75 column and 20  mM sodium acetate 
buffer pH 5.0 containing 100  mM NaCl as the mobile 
phase. All chromatography buffers contained 0.02% (w/v) 
NaN3 as a microbial inhibitor. SDS-PAGE and anti-Cel7A 
immunoblotting were performed to assess purity.
Fluorescence quantitation
A small mycelial fragment from a transformant col-
ony was transferred to 24-well plates containing MAG 
medium (with hygromycin) and incubated for 3 days at 
30 °C to allow mycelial mat formation. Following growth 
of the mycelial mat, plates were directly visualized in a 
FLUOstar Omega plate reader (BMG Labtech GmbH, 
Ortenburg, Germany) using excitation wavelength of 
485  nm and an emission wavelength of 520  nm. Each 
plate included a control eGFP-Cel7A-co-expressing 
strain (SV004), a Cel7A-expressing strain (JLT102A), and 
a Cel7A-deleted strain (AST1116).
Cel7A enzyme activity measurement
Cellobiohydrolase (Cel7A) activity was based on the 
conversion of the cellulose fraction of a standard dilute 
acid-pretreated corn stover (PCS) using a cocktail of 
the subject Cel7A mixed with two other standardized 
cellulases. Specifically, the purified Cel7A was loaded 
at 28  mg/g of biomass cellulose and the two ancillary 
enzymes, the endoglucanase Acidothermus cellulolyticus 
E1 cdY245G (Cel5A, catalytic domain, Y245G mutant) 
and chromatographically purified β-d-glucosidase from 
Aspergillus niger, were loaded at 1.89 and 0.5 mg/g bio-
mass cellulose, respectively.
The Cel7A activity assay was performed essentially as 
described in Linger et  al. [5]. Briefly, the biomass sub-
strate, NREL dilute acid-pretreated corn stover P050921 
(59.1% glucan, 25.3% lignin, 5.1% xylan), was washed with 
water and then with 20  mM acetic acid/sodium acetate 
buffer, pH 5.0, until the pH of the wash supernatant was 
within 0.03 units of pH 5.0 [20]. From a slurry of this 
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washed biomass material, a series of biomass substrate 
aliquots were prepared in 2.0-mL high-performance liq-
uid chromatography (HPLC) vials, in such a way that 
each vial contained 8.5  mg biomass cellulose. Biomass 
dry weights for this batch of assay vials was verified by 
dry weight determinations on a group of five samples co-
pipetted into pre-tared vials. Adjustment of these biomass 
assay aliquots to a 1.7 mL final volume was done by the 
addition of the enzyme cocktail, which resulted in a cel-
lulose concentration of 5.0 mg/mL in the assay mixture.
Assays were carried out in triplicate vials at 40  °C in 
20  mM acetate buffer pH 5.0 containing 0.02% NaN3 
with continuous mixing by inversion at 10  rpm while 
immersed in a water bath. At various times during the 
digestion, vials were removed from the rotator, and repre-
sentative 100 μL samples containing both solids and liquid 
were removed from the well-mixed contents and diluted 
18 folds into glass HPLC vials. The primary digestion vials 
were immediately resealed and returned to the rotator for 
continuation of the digestion process. The vials containing 
the samples were crimp-sealed and immersed in a boil-
ing water bath to terminate the reaction. Quantification 
of released sugars was performed by high-performance 
liquid chromatography using a Bio-Rad HPX-87H column 
operated at 55 °C with 0.01 N H2SO4 as eluent at 0.6 mL/
min and refractive index detection.
Additional files
Additional file 1. Primers used for PCR analysis.
Additional file 2. Detection of Cel7A and eGFP proteins in the selected 
C2G transformants. A. Extracellular Cel7A detection using anti-Cel7A anti-
body. B. Intracellular eGFP detection using anti-eGFP antibody. Lanes M. 
Molecular weight marker; A1, C2, C4, C5,D1, D3, A2 and A4, transformant 
colonies; Ast, AST1114 (Cel7A deleted T. reesei QM6A strain); JLT, JLT102A 
(AST1116 expressing native Cel7A under the eno promoter); SV004, 
AST1116 expressing Cel7A-2A-eGFP.
Additional file 3. Detection of Cel7A and eGFP proteins in the selected 
G2C transformants. A. Extracellular Cel7A detection using anti-Cel7A anti-
body. B. Intracellular eGFP detection using anti-eGFP antibody. Lanes M. 
Molecular weight marker; C6, D1, C2, A1, A2, C3, C4 and B1, transformant 
colonies; Ast, AST1114 (Cel7A deleted T. reesei QM6A strain); JLT, JLT102A 
(AST1116 expressing native Cel7A under the eno promoter); SV004, 
AST1116 expressing Cel7A-2A-eGFP.
Additional file 4. PCR analysis to determine the presence of cel7A, eGFP 
and both in the C2G transformants. Lanes M. Molecular weight marker 
(GeneRuler 1kb DNA ladder); A1, C2, C4, C5,D1, D3, A2 and A4, C2G trans-
formant colonies; AST1114, Cel7A deleted T. reesei QM6A strain); JLT102A, 
AST1116 expressing native Cel7A under the eno promoter; SV001 and 
SV002, AST1116 expressing eGFP-2A-Cel7A; SV004, AST1116 expressing 
Cel7A-2A-eGFP.
Additional file 5. PCR analysis to determine the presence of cel7A, 
eGFP and both in the G2C transformants. PCR analysis to determine the 
presence of cel7A, eGFP and both in the G2C transformants. Lanes M. 
Molecular weight marker (GeneRuler 1kb DNA ladder); C6, D1, C2, C3, A1, 
A2 C4 and B1, G2C transformant colonies; AST1114, Cel7A deleted T. reesei 
QM6A strain); JLT102A, AST1116 expressing native Cel7A under the eno 
promoter; SV001 and SV002, AST1116 expressing eGFP-2A-Cel7A; SV004, 
AST1116 expressing Cel7A-2A-eGFP.
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